2025
SJR Q1
JCR Q1 · 5,5
OA
6 matched articles
SCIE
Journal detail
Journal of Pharmacy and Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
14821826
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,106
- Quartile Q1
- H-Index 95
- Cites/doc 4,72
- Docs (3y) 84
- Cites (3y) 423
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,5
- 5Y JIF 3,7
- JCI 1,06
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q1
- Pharmaceutical Science Q1
- Pharmacology Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,106 | 5,5 | 3,7 | 1,06 | Q1 | 95 |
| 2024 | Q2 | Q1 | 0,72 | 4,3 | 2,9 | 0,89 | Q2 | 92 |
| 2023 | Q2 | Q2 | 0,619 | 2,9 | 2,6 | 0,84 | Q2 | 92 |
| 2022 | Q2 | Q3 | 0,566 | 2,7 | 3 | 0,7 | Q2 | 92 |
| 2021 | Q2 | Q3 | 0,547 | 3,3 | 3,2 | 0,65 | Q2 | 92 |
| 2020 | Q2 | Q3 | 0,497 | 2,3 | 2,9 | 0,49 | Q3 | 92 |
| 2019 | Q2 | Q4 | 0,399 | 1,7 | 2,4 | 0,48 | Q3 | 92 |
| 2018 | — | Q3 | — | 1,9 | 2,6 | 0,56 | Q3 | — |
| 2017 | Q2 | Q3 | 0,574 | 2,3 | 2,8 | 0,61 | Q3 | 92 |
| 2016 | Q2 | Q3 | 0,592 | 1,8 | 2,3 | — | — | 92 |
| 2015 | Q1 | Q3 | 0,719 | 2,3 | 2,5 | — | — | 92 |
| 2014 | Q1 | Q3 | 0,652 | 1,9 | 2,4 | — | — | 92 |
| 2013 | Q1 | Q3 | 0,624 | 1,7 | 2,5 | — | — | 92 |
| 2012 | Q1 | Q2 | 0,793 | 2,2 | 2,6 | — | — | 92 |
| 2011 | Q1 | Q3 | 0,587 | 1,6 | 2,3 | — | — | 92 |
| 2010 | Q1 | Q3 | 0,615 | 1,9 | 2,5 | — | — | 92 |
| 2009 | — | Q3 | — | 1,6 | 2,1 | — | — | — |
| 2008 | — | Q3 | — | 1,9 | 2,6 | — | — | — |
| 2007 | — | Q3 | — | 1,7 | 2,2 | — | — | — |
| 2006 | — | Q3 | — | 1,6 | — | — | — | — |
| 2005 | — | Q2 | — | 2 | — | — | — | — |
| 2004 | — | Q3 | — | 1,1 | — | — | — | — |
| 2003 | — | Q3 | — | 1,3 | — | — | — | — |
| 2002 | — | Q3 | — | 1,5 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 56/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q2 | 69/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 147/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 177/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 155/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 206/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 223/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 186/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 143/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 179/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 157/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 168/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 130/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 172/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 161/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 132/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 128/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 122/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 88/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 113/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 96/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 139/186 |